Business Description
A Plus Biotechnology Co Ltd
ISIN : TW0006918006
Description
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.83 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | 1.52 | |||||
| Interest Coverage | 62 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.82 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.2 | |||||
| 3-Year EBITDA Growth Rate | -1.8 | |||||
| 3-Year EPS without NRI Growth Rate | -0.2 | |||||
| 3-Year FCF Growth Rate | 9.8 | |||||
| 3-Year Book Growth Rate | 2.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.9 | |||||
| 9-Day RSI | 64.11 | |||||
| 14-Day RSI | 69.41 | |||||
| 6-1 Month Momentum % | 30.59 | |||||
| 12-1 Month Momentum % | 34.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.39 | |||||
| Quick Ratio | 3.4 | |||||
| Cash Ratio | 2.24 | |||||
| Days Inventory | 495.3 | |||||
| Days Sales Outstanding | 75.82 | |||||
| Days Payable | 57.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.02 | |||||
| Dividend Payout Ratio | 0.68 | |||||
| Forward Dividend Yield % | 1.02 | |||||
| 5-Year Yield-on-Cost % | 1.01 | |||||
| 3-Year Average Share Buyback Ratio | -1.9 | |||||
| Shareholder Yield % | 3.15 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.24 | |||||
| Operating Margin % | 24.84 | |||||
| Net Margin % | 4.62 | |||||
| FCF Margin % | 22.12 | |||||
| ROE % | 3.55 | |||||
| ROA % | 2.7 | |||||
| ROIC % | 15.21 | |||||
| ROC (Joel Greenblatt) % | 8.44 | |||||
| ROCE % | 4.86 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 66.79 | |||||
| PE Ratio without NRI | 66.53 | |||||
| Price-to-Owner-Earnings | 248.03 | |||||
| PS Ratio | 3.09 | |||||
| PB Ratio | 2.39 | |||||
| Price-to-Tangible-Book | 2.54 | |||||
| Price-to-Free-Cash-Flow | 13.94 | |||||
| Price-to-Operating-Cash-Flow | 13.09 | |||||
| EV-to-EBIT | 38.78 | |||||
| EV-to-EBITDA | 25.07 | |||||
| EV-to-Revenue | 2.77 | |||||
| EV-to-FCF | 12.6 | |||||
| Price-to-Graham-Number | 2.74 | |||||
| Price-to-Net-Current-Asset-Value | 3.95 | |||||
| Price-to-Net-Cash | 27.09 | |||||
| Earnings Yield (Greenblatt) % | 2.57 | |||||
| FCF Yield % | 7.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
A Plus Biotechnology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 675.047 | ||
| EPS (TTM) (NT$) | 1.03 | ||
| Beta | 0 | ||
| Volatility % | 42.41 | ||
| 14-Day RSI | 69.41 | ||
| 14-Day ATR (NT$) | 1.889221 | ||
| 20-Day SMA (NT$) | 65.815 | ||
| 12-1 Month Momentum % | 34.38 | ||
| 52-Week Range (NT$) | 41.05 - 74 | ||
| Shares Outstanding (Mil) | 30.18 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
A Plus Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
A Plus Biotechnology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
A Plus Biotechnology Co Ltd Frequently Asked Questions
What is A Plus Biotechnology Co Ltd(ROCO:6918)'s stock price today?
The current price of ROCO:6918 is NT$68.80. The 52 week high of ROCO:6918 is NT$74.00 and 52 week low is NT$41.05.
When is next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918)?
The next earnings date of A Plus Biotechnology Co Ltd(ROCO:6918) is .
Does A Plus Biotechnology Co Ltd(ROCO:6918) pay dividends? If so, how much?
The Dividend Yield %  of A Plus Biotechnology Co Ltd(ROCO:6918) is 1.02% (As of Today), Highest Dividend Payout Ratio of A Plus Biotechnology Co Ltd(ROCO:6918) was 0.68. The lowest was 0.68. And the median was 0.68. The  Forward Dividend Yield % of A Plus Biotechnology Co Ltd(ROCO:6918) is 1.02%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers